Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease

2008541 citationsJournal Articlebronze Open Access

Authors

Edward L. Hannan · University at Albany, State University of New York

Chuntao Wu · University at Albany, State University of New York

Gary Walford · St Joseph's Hospital Health Center

Alfred T. Culliford · Columbia University Irving Medical Center

Jeffrey P. Gold · University of Toledo Medical Center

Craig R. Smith · NewYork–Presbyterian Hospital

Robert S.D. Higgins

Abstract

For patients with multivessel disease, CABG continues to be associated with lower mortality rates than does treatment with drug-eluting stents and is also associated with lower rates of death or myocardial infarction and repeat revascularization.

Topics & Keywords

Coronary Interventions and Diagnostics Antiplatelet Therapy and Cardiovascular Diseases Cerebrovascular and Carotid Artery Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 358, Issue 4, pp. 331-341

DOI: 10.1056/nejmoa071804

Field-Weighted Citation Impact: 61.83